Company Filing History:
2 out of 950 
1 out of 987 
Years Active: 2025
Title: Hitoshi Katada: Innovator in Antibody Research
Introduction
Hitoshi Katada is a prominent inventor based in Singapore, known for his contributions to the field of antibody research. He holds 2 patents that focus on innovative methods and applications of anti-CTLA-4 antibodies. His work has significant implications in the medical and biotechnological sectors.
Latest Patents
Hitoshi Katada's latest patents include the development of anti-CTLA-4 antibodies and methods for their production and use. The disclosures provide detailed information on nucleic acids encoding these antibodies and host cells that contain them. Additionally, the patents describe polypeptides with a variant Fc region that includes amino acid alterations, along with methods for producing and utilizing these polypeptides.
Career Highlights
Throughout his career, Hitoshi Katada has worked with notable organizations such as Chugai Seiyaku Kabushiki Kaisha and Osaka University. His experience in these institutions has contributed to his expertise in antibody research and development.
Collaborations
Hitoshi has collaborated with several professionals in his field, including Kanako Tatsumi and Shun Shimizu. These collaborations have further enhanced his research and innovation capabilities.
Conclusion
Hitoshi Katada is a significant figure in the realm of antibody research, with a focus on anti-CTLA-4 antibodies. His patents and career achievements reflect his dedication to advancing medical science and biotechnology.